Dapagliflozin in young people with type 2 diabetes

Lancet Diabetes Endocrinol. 2022 May;10(5):303-304. doi: 10.1016/S2213-8587(22)00075-4. Epub 2022 Apr 1.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Adolescent
  • Benzhydryl Compounds / therapeutic use
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucosides / therapeutic use
  • Humans
  • Hypoglycemic Agents / therapeutic use

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Hypoglycemic Agents
  • dapagliflozin